Literature DB >> 28544119

Common Fibril Structures Imply Systemically Conserved Protein Misfolding Pathways In Vivo.

Karthikeyan Annamalai1, Falk Liberta1, Marie-Theres Vielberg2, William Close1, Hauke Lilie3, Karl-Heinz Gührs4, Angelika Schierhorn5, Rolf Koehler6, Andreas Schmidt1, Christian Haupt1, Ute Hegenbart7, Stefan Schönland7, Matthias Schmidt1, Michael Groll2, Marcus Fändrich1.   

Abstract

Systemic amyloidosis is caused by the misfolding of a circulating amyloid precursor protein and the deposition of amyloid fibrils in multiple organs. Chemical and biophysical analysis of amyloid fibrils from human AL and murine AA amyloidosis reveal the same fibril morphologies in different tissues or organs of one patient or diseased animal. The observed structural similarities concerned the fibril morphology, the fibril protein primary and secondary structures, the presence of post-translational modifications and, in case of the AL fibrils, the partially folded characteristics of the polypeptide chain within the fibril. Our data imply for both analyzed forms of amyloidosis that the pathways of protein misfolding are systemically conserved; that is, they follow the same rules irrespective of where inside one body fibrils are formed or accumulated.
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Alzheimer's disease; Parkinson's disease; conformational disease; prions; protein aggregation

Mesh:

Substances:

Year:  2017        PMID: 28544119     DOI: 10.1002/anie.201701761

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  22 in total

Review 1.  Amyloid fibril polymorphism: a challenge for molecular imaging and therapy.

Authors:  M Fändrich; S Nyström; K P R Nilsson; A Böckmann; H LeVine; P Hammarström
Journal:  J Intern Med       Date:  2018-02-19       Impact factor: 8.989

2.  Protease-sensitive regions in amyloid light chains: what a common pattern of fragmentation across organs suggests about aggregation.

Authors:  Giulia Mazzini; Stefano Ricagno; Serena Caminito; Paola Rognoni; Paolo Milani; Mario Nuvolone; Marco Basset; Andrea Foli; Rosaria Russo; Giampaolo Merlini; Giovanni Palladini; Francesca Lavatelli
Journal:  FEBS J       Date:  2021-09-15       Impact factor: 5.622

3.  Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.

Authors:  Pamina Kazman; Marie-Theres Vielberg; María Daniela Pulido Cendales; Lioba Hunziger; Benedikt Weber; Ute Hegenbart; Martin Zacharias; Rolf Köhler; Stefan Schönland; Michael Groll; Johannes Buchner
Journal:  Elife       Date:  2020-03-10       Impact factor: 8.140

4.  Structure and energetic basis of overrepresented λ light chain in systemic light chain amyloidosis patients.

Authors:  Jun Zhao; Baohong Zhang; Jianwei Zhu; Ruth Nussinov; Buyong Ma
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-12-12       Impact factor: 5.187

5.  Structural Polymorphs Suggest Competing Pathways for the Formation of Amyloid Fibrils That Diverge from a Common Intermediate Species.

Authors:  Lauren E Buchanan; Michał Maj; Emily B Dunkelberger; Pin-Nan Cheng; James S Nowick; Martin T Zanni
Journal:  Biochemistry       Date:  2018-11-06       Impact factor: 3.162

Review 6.  Half a century of amyloids: past, present and future.

Authors:  Pu Chun Ke; Ruhong Zhou; Louise C Serpell; Roland Riek; Tuomas P J Knowles; Hilal A Lashuel; Ehud Gazit; Ian W Hamley; Thomas P Davis; Marcus Fändrich; Daniel Erik Otzen; Matthew R Chapman; Christopher M Dobson; David S Eisenberg; Raffaele Mezzenga
Journal:  Chem Soc Rev       Date:  2020-07-07       Impact factor: 54.564

7.  Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient.

Authors:  Paolo Swuec; Francesca Lavatelli; Masayoshi Tasaki; Cristina Paissoni; Paola Rognoni; Martina Maritan; Francesca Brambilla; Paolo Milani; Pierluigi Mauri; Carlo Camilloni; Giovanni Palladini; Giampaolo Merlini; Stefano Ricagno; Martino Bolognesi
Journal:  Nat Commun       Date:  2019-03-20       Impact factor: 14.919

8.  Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer's and Pick's diseases.

Authors:  Wenjuan Zhang; Benjamin Falcon; Alexey G Murzin; Juan Fan; R Anthony Crowther; Michel Goedert; Sjors Hw Scheres
Journal:  Elife       Date:  2019-02-05       Impact factor: 8.140

9.  Cryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloids.

Authors:  Falk Liberta; Sarah Loerch; Matthies Rennegarbe; Angelika Schierhorn; Per Westermark; Gunilla T Westermark; Bouke P C Hazenberg; Nikolaus Grigorieff; Marcus Fändrich; Matthias Schmidt
Journal:  Nat Commun       Date:  2019-03-07       Impact factor: 14.919

10.  Physical basis of amyloid fibril polymorphism.

Authors:  William Close; Matthias Neumann; Andreas Schmidt; Manuel Hora; Karthikeyan Annamalai; Matthias Schmidt; Bernd Reif; Volker Schmidt; Nikolaus Grigorieff; Marcus Fändrich
Journal:  Nat Commun       Date:  2018-02-16       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.